Costly Protocols Unnecessary? How much you gain by cutting them out of your clinical development 5 July 2012 / By YuenLing / Clinical Trials, Drug Safety, Regulation and Government, Reports / 1 comment
FEATURED SPEAKER: Werner Katzmann, Biogen Idec, Singapore 13 December 2011 / By YuenLing / Clinical Trials / 0 comments
